Mon, March 5, 2012
[ Mon, Mar 05th 2012 ]: Market Wire
VistaGen Therapeutics and Duke University Enter Into Strategic Research Collaboration
[ Mon, Mar 05th 2012 ]: Market Wire
Lilly Pledges $100,000 to American Red Cross' Tornado Disaster Relief Efforts
[ Mon, Mar 05th 2012 ]: Market Wire
BIOLASE Declares Stock Dividend for 2012 First Quarter
[ Mon, Mar 05th 2012 ]: Market Wire
Access Pharmaceuticals Announces Preliminary Four .. 9; MuGard Product Revenue Increases 400% Quar
[ Mon, Mar 05th 2012 ]: Market Wire
New Stem Cell Research Shows Promising Results -- Advanced Cell Tech and NeoStem Poised to Benefit
[ Mon, Mar 05th 2012 ]: Market Wire
BioTime and Aastrom Biosciences -- Stem Cell Research Making Breakthroughs
[ Mon, Mar 05th 2012 ]: Market Wire
Liezel Huber Hopes to Dominate at This Week's BNP Paribas Open
[ Mon, Mar 05th 2012 ]: Market Wire
Unigene's Proprietary Peptelligencea" Platform Se .. ealth Peptides for an Oral Phase 1 Clinical Study
[ Mon, Mar 05th 2012 ]: Market Wire
Sequenom Announces Participation at the 24th Annual Roth OC Growth Stock Conference
[ Mon, Mar 05th 2012 ]: Market Wire
Cytokinetics Announces Fundamental Research in th .. le Activation Published in the Journal Nature Med
[ Mon, Mar 05th 2012 ]: Market Wire
BioDelivery Sciences to Present at Cowen and ROTH Conferences
[ Mon, Mar 05th 2012 ]: Market Wire
Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference
[ Mon, Mar 05th 2012 ]: Market Wire
The Ensign Group Announces Acquisition of Doctors Express Franchise System
[ Mon, Mar 05th 2012 ]: Market Wire
OncoSec to Present at Cowen and ROTH Healthcare Conferences
[ Mon, Mar 05th 2012 ]: Market Wire
BioLife Solutions Commences Build-Out of Second G .. P Production Suite and Corporate Office Expansion
[ Mon, Mar 05th 2012 ]: Market Wire
Inovio Therapeutic Vaccine for Head amp;; .. ncers Induces Robust T-Cell Immune Response in Mi
[ Mon, Mar 05th 2012 ]: Market Wire
Inovio Therapeutic Vaccine for Head & Neck and Ot .. ers Induces Robust T-Cell Immune Response in Mice
[ Mon, Mar 05th 2012 ]: Market Wire
diaDexus Launches PLAC Test for Lp-PLA(2) Activity in Europe
Fri, March 2, 2012
[ Fri, Mar 02nd 2012 ]: Market Wire
Warnex Extends Maturity Date of its Outstanding D .. entures and Provides Update on its Listing Status
[ Fri, Mar 02nd 2012 ]: Market Wire
Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence
[ Fri, Mar 02nd 2012 ]: Market Wire
Syneron Closes Acquisition of Ultrashape Ltd.
[ Fri, Mar 02nd 2012 ]: Market Wire
Growing Medical Need for Cancer and Inflammation Treatment Benefits Cell Therapeutics and Zalicus
[ Fri, Mar 02nd 2012 ]: Market Wire
Amerigroup Expands Operations in Texas
[ Fri, Mar 02nd 2012 ]: Market Wire
Arena Pharmaceuticals Files European Marketing Au .. ion Application for Lorcaserin for Weight Control
[ Fri, Mar 02nd 2012 ]: Market Wire
Amgen Announces Initial Results of Tender Offer f .. omet, Inc. and Commencement of Subsequent Offerin
[ Fri, Mar 02nd 2012 ]: Market Wire
Orexigen Therapeutics Schedules March 8, 2012 Web .. Results for the Fourth Quarter and Year Ended Dec
[ Fri, Mar 02nd 2012 ]: Market Wire
BioSpecifics Technologies Corp. to Host Conferenc .. ter and Full Year 2011 Financial Results on March
[ Fri, Mar 02nd 2012 ]: Market Wire
ProMetic Announces Changes to Its Board of Directors
[ Fri, Mar 02nd 2012 ]: Market Wire
Given Imaging Supports Fight Against Colorectal Cancer
[ Fri, Mar 02nd 2012 ]: Market Wire
SciClone Announces Results of Interim Analysis of Phase 2 SCV-07 Oral Mucositis Trial
[ Fri, Mar 02nd 2012 ]: Market Wire
Media Advisory - Oncolytics Biotech Inc. to Prese .. en and Company 32nd Annual Health Care Conference
[ Fri, Mar 02nd 2012 ]: Market Wire
Delcath to Conduct Conference Call to Discuss Full Year 2011 Results and Recent Corporate Progress
[ Fri, Mar 02nd 2012 ]: Market Wire
IRIDEX to Present at Upcoming Investment Conferences
[ Fri, Mar 02nd 2012 ]: Market Wire
NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production
[ Fri, Mar 02nd 2012 ]: Market Wire
Concord Medical to Report Fourth Quarter and Full Year 2011 Financial Results on March 21, 2012
Thu, March 1, 2012
[ Thu, Mar 01st 2012 ]: Market Wire
Pipeline promise confirmed: mixed financial results for 2011, but with excellent outlook for 2012
[ Thu, Mar 01st 2012 ]: Market Wire
Galapagos receives EUR3.5 million in milestones in osteoarthritis alliance with Servier
[ Thu, Mar 01st 2012 ]: Market Wire
GAMCO Natural Resources, Gold & Income Trust by G .. Declares Monthly Distributions of $0.14 Per Share
[ Thu, Mar 01st 2012 ]: Market Wire
Universal American Corp. to Present at the Raymon .. onal Investors Conference on Wednesday, March 7th
[ Thu, Mar 01st 2012 ]: Market Wire
Pharmacyclics to Host a Conference Call on March .. arter Fiscal 2012 Financial and Operational Resul
[ Thu, Mar 01st 2012 ]: Market Wire
Humana Inc. to Present at the Cowen and Company 2012 Health Care Conference
[ Thu, Mar 01st 2012 ]: Market Wire
Rocky Mountain Health Plans, Healthways Announce .. rm Extension of Total Population Health Solutions
[ Thu, Mar 01st 2012 ]: Market Wire
Sun Healthcare Group, Inc. to Present at the Barclays Capital Global Healthcare Conference
[ Thu, Mar 01st 2012 ]: Market Wire
AVI BioPharma Announces Fourth Quarter and Full Y .. nancial Results and Recent Corporate Developments
[ Thu, Mar 01st 2012 ]: Market Wire
Idenix Pharmaceuticals Elects Thomas Hodgson as C .. Appoints Michael Wyzga to Its Board of Directors
[ Thu, Mar 01st 2012 ]: Market Wire
Watson to Present at the Barclays Capital 2012 Global Healthcare Conference
[ Thu, Mar 01st 2012 ]: Market Wire
IMRIS reports fourth quarter and annual 2011 financial results
[ Thu, Mar 01st 2012 ]: Market Wire
Halozyme to Host Fourth Quarter and 2011 Year-End Financial Results Conference Call

AMAG Pharmaceuticals, Inc. to Present at the 24th Annual ROTH Conference

LEXINGTON, Mass.--([ ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate at the 24th Annual ROTH Conference on March 13 at 4:30 pm PT in Dana Point, CA. Company management will provide an overview of the company followed by a question and answer period with investors.

A live webcast of the presentation will be accessible through the Investors section of the Companyas website at [ www.amagpharma.com ]. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until April 13, 2012.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit [ www.amagpharma.com ].